Ask the Experts: Hematology-Oncology
Medscape's Ask the Experts allows you to ask members of a panel of leading experts for advice or information. You also have the opportunity to share your own views and insights by clicking the "Discuss this" link at the top of each response.
Ask the Experts
- Multimodality Approaches to a Postmastectomy Local Breast Cancer Recurrence
- Primary Treatment of Breast Cancer in a Patient With Breast Implants
- Can Opiates Be Administered by Nebulizer?
- How Should the APN Code for a Counseling Visit?
- Adjuvant Chemotherapy and Radiation Therapy for Breast Cancer: What Is the Optimal Sequence?
- How Do I Select the Right Adjuvant Chemotherapy Regimen for My Patient With Breast Cancer?
- What Is the Maximum Safe Dose of Opioids?
- Locoregional Recurrence of Breast Cancer After Mastectomy
- Do Antihistamines Relieve Drug-Induced Bone Pain?
- Can Fentanyl Patches Be Replaced Sooner to Improve Pain Control?
- Triple-Negative Invasive Breast Cancer: Adjuvant Treatment Choices After Lumpectomy
- Treating Hot Flashes Induced by Tamoxifen
- Treatment for an Endoscopically Resected Polyp When the Histologic Findings Show Adenocarcinoma?
- Can Ondansetron Be Administered Transdermally?
- What Is the Role of Rosiglitazone in Steroid-Induced Diabetes?
- Combining Duragesic Patches With Other Pain Medications
- Subcutaneous Immunoglobulin in the Management of Primary Immunodeficiency
- Combining Long-acting Opioids That Are Active at Different mu Receptors for Pain Management
- Combining Methadone With Other Long-acting and Short-acting Opioids for Pain Management
- Keratinizing Squamous Metaplasia
Disclaimer
The information in this web site reflects the views of the authors only and not Medscape. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers should verify all information and data before treating patients or utilizing any therapies noted in this program.
Ask a Question
Ask a Question
Ask Medscape's Expert Panel Clinical Questions on the following topics:
Harold J. Burstein, MD, PhD, Assistant Professor, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.
Avraham Eisbruch, MD, Professor of Radiation Oncology, University of Michigan, and Clinical Division Director, University of Michigan Hospital, Ann Arbor, MI.
John D. Hainsworth, MD, Director, Clinical Research, Sarah Cannon Cancer Center, Nashville, Tennessee.
Manuel Hidalgo, MD, Associate Professor, Director, Johns Hopkins University, Baltimore, Maryland.
Clifford Hudis, MD, Chief, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY; Associate Professor of Medicine, Joan and Sanford I. Weill Medical College, Cornell University, New York, NY.
Corey J. Langer, MD, Associate Professor of Medicine, Temple University, Philadelphia, Pennsylvania; Medical Director, Thoracic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
John S. Macdonald, MD, Professor of Medicine, New York Medical College, Valhalla, New York; Chief, Gastrointestinal Oncology Service, St. Vincent's Catholic Medical Center-Manhattan, New York, NY.
Marshall Posner, MD, Associate Professor of Medicine, Adult Oncology; Medical Director, Head and Neck Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Kathleen I. Pritchard, MD, FRCPC, Head, Clinical Trials and Epidemiology, Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada; Clinical Director, Ontario Clinical Oncology Group, Toronto, Ontario, Canada.
Joseph A. Sparano, MD, Professor of Medicine, Albert Einstein College of Medicine, Bronx, New York; Director, Breast Evaluation Center, Montefiore-Einstein Cancer Center, Bronx, New York.
Paul A. Vasey MSc, MD, MRCP, Senior Lecturer in Medical Oncology and Honorary Consultant Cancer Physician, Cancer Research Campaign Department of Medical Oncology, University of Glasgow and Beatson Oncology Centre, Glasgow, Scotland, UK.